| Feasibility of contact heat evoked potentials for detection of diabetic neuropathy. | |
| | |
MedLine Citation:
|
PMID: 22102460 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Introduction: The involvement of small myelinated fibers in the early stages of diabetic neuropathy (DN) has been suggested, but few objective methods can identify minimal neuropathy. The purpose of this study was to determine whether there are differences in contact heat evoked potential (CHEP) parameters between healthy adults and diabetics with and without lower limb symptoms. Methods: CHEP was recorded at the midline channels. A peak stimulating temperature of 51°C was applied to the dorsum of the foot and at a point 10 cm proximal to the lateral malleolus. Results: There was a significant difference in N1-P1 amplitude in the three groups after stimulation of the dorsum of the foot (P = 0.028) and the point 10 cm proximal to the lateral malleolus (P = 0.006). Discussion: CHEP can help to detect early A-delta fiber damage in diabetic patients with minimal neuropathy. Muscle Nerve, 2011. |
| | |
Authors:
|
Man-Chun Wong; Joanne W Y Chung |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Muscle & nerve Volume: 44 ISSN: 1097-4598 ISO Abbreviation: Muscle Nerve Publication Date: 2011 Dec |
Date Detail:
|
Created Date: 2011-11-21 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7803146 Medline TA: Muscle Nerve Country: United States |
Other Details:
|
Languages: eng Pagination: 902-6 Citation Subset: IM |
Copyright Information:
|
Copyright © 2011 Wiley Periodicals, Inc. |
Affiliation:
|
Department of Nursing and Health Sciences, Tung Wah College, 31 Wiley Road, Homantin, Kowloon, Hong Kong. wongmc0829@yahoo.com.hk. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Correction and transformation of normative neurophysiological data: Is there added value in the diag...
Next Document: Cost analysis of myasthenia gravis from a large U.S. insurance database.